Skip to main content
Livermore
Livermore
ZHEN

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

LCTX holding history

Lineage Cell Therapeutics, Inc. in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LCTX overviewAll 13F holders of LCTXFull Q2 2026 holdings

Shares (Q2 2026)
99,870
Value
$130.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of LCTX by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202699,870$130.8K<0.1%00.0%UnchangedHolders
Q1 202699,870$157.8K<0.1%+1,500+1.5%AddedHolders
Q4 202598,370$164.3K<0.1%00.0%UnchangedHolders
Q3 202598,370$166.2K<0.1%+40,664+70.5%AddedHolders
Q2 202557,706$52.4K<0.1%00.0%UnchangedHolders
Q1 202557,706$26.1K<0.1%00.0%UnchangedHolders
Q4 202457,706$29.0K<0.1%+19,100+49.5%AddedHolders
Q3 202438,606$35.0K<0.1%−17,065−30.7%ReducedHolders
Q2 202455,671$56.0K<0.1%−8,300−13.0%ReducedHolders
Q1 202463,971$95.0K<0.1%+9,900+18.3%AddedHolders
Q4 202354,071$59.0K<0.1%00.0%UnchangedHolders
Q3 202354,071$64.0K<0.1%+19,955+58.5%AddedHolders
Q2 202334,116$48.0K<0.1%−16,000−31.9%ReducedHolders
Q1 202350,116$75.0K<0.1%+16,000+46.9%AddedHolders
Q4 202234,116$40.0K<0.1%+700+2.1%AddedHolders
Q3 202233,416$37.0K<0.1%00.0%UnchangedHolders
Q2 202233,416$53.0K<0.1%00.0%UnchangedHolders
Q1 202233,416$51.0K<0.1%00.0%UnchangedHolders
Q4 202133,416$82.0K<0.1%+100+0.3%AddedHolders
Q3 202133,316$84.0K<0.1%+17,000+104.2%AddedHolders
Q2 202116,316$46.0K<0.1%00.0%UnchangedHolders
Q1 202116,316$38.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.